|
Sign In to gain access to subscriptions and/or personal tools.
|
Immunohistochemical Markers for the Rodent Immune System
Jerrold M. Ward1,
Cindy R. Erexson1,
Lawrence J. Faucette1,
Julie F. Foley2,
Christine Dijkstra3 and
Giorgio Cattoretti4
1 Comparative Medicine Branch, NIAID, NIH, Bethesda, Maryland 20892-8135, USA
2 Laboratory of Experimental Pathology, NIEHS, NIH, Research Triangle Park, North Carolina 27709, USA
3 Department of Molecular Cell Biology and Immunology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands
4 Institute for Cancer Genetics, Columbia University, RBP, New York 10032, USA
Correspondence: Address correspondence to: Dr. J. M. Ward, Comparative Medicine Branch, NIAID, NIH, Bethesda, MD 20892-8135, USA; e-mail:jw116y{at}nih.gov
 |
Abstract
|
|---|
The responses to insults including chemical toxins, irradiation and infectious agents involve morphologic, biochemical and molecular changes in the immune system. The changes in specific tissues and cells often can be detected by histopathology and its associated field of immunohistochemisty (IHC). Cells normally express specific proteins (antigens) that can be detected by IHC. When responses to xenobiotics occur, cells often up or down regulate proteins. The art of IHC requires specialized procedures for detection of antigens. Fixation, tissue processing, immunoreactions and antigen retrieval methods are important elements of IHC. We review the antibodies, their sources, use of frozen or fixed paraffin-embedded tissues and specific IHC methods including antigen retrieval and illustrate how they can be effectively used to characterize the immunotoxicologic effects of agents.
Key Words: Tissue fixation • antigen retrieval • rat • mouse • B cells • T cells
|
Introduction
|
|---|
Exposure of rodents to exogenous agents including toxins and infectious agents often involves responses in the immune system. Toxicity in the immune system may include degenerative, necrotizing, proliferative and neoplastic responses. The nature and extent of the responses may be agent and dose related. The responses are often measured with biochemical, molecular, cytological, and histopathological methods. Histopathology can demonstrate morphologic changes in normal anatomical and histological structure of thymus, lymph nodes, spleen, Peyer’s patches, and lymphoid cells and tissues in other organs. Gene expression, as detected by antigens in cells and tissues by immunohistochemical (IHC) methods, can provide an excellent adjunct to routine histopathology. Normal distribution of cells expressing specific antigens can be studied with frozen and paraffin sections with a variety of antibodies and IHC methods. The changes in cells and tissues can be assessed and immunotoxicity characterized. This review describes IHC techniques the authors have used in 4 different research laboratories over the past years. We include screening methods for basic markers of the immune cells as well as more detailed methods of analysis.
|
Technical Considerations
|
|---|
The fixative, specific antibodies, sources of the antibodies, and IHC methods play an important role in IHC. Many aspects of these important considerations have been reviewed in several excellent books and reviews (Romas-Vara et al., 2005). We will not review these considerations here except for some that apply to rodents.
Sources of Antibodies for Rat and Mouse IHC
Major commercial sources of antibodies against specific rodent antigens include BD Biosciences, Serotec, and Santa Cruz Biotechnology, but many other sources also exist. If antigens, such as CD3 and immunoglobulin kappa light chains, are well conserved in many species, anti-human antibodies work well in mice. Frozen sections are the optimal material to use and hundreds of antibodies against rodent antigens work well with frozen sections (BD Biosciences Mouse CD Chart  http://www.bdbiosciences.com/pdfs/other/01-81004-36.pdf , BD Biosciences Rat CD Chart http://www.bdbiosciences.com/pdfs/other/03-8100095-11A.pdf, and a subset work well with paraffin embedded tissues (Cattoretti and Fei, 2000; van den Berg et al. 2001a, 2001b; G. Cattoretti, http://icg.cpmc.columbia.edu/cattoretti/Protocol/Mouse_IHC/Antibodies for mouse IHC.html; Haines et al., 2001; Meyer et al., 1979; Mikaelian et al., 2004; Mikaelian et al. http://tumor.informatics.jax.org/mtbwi/immunohistochemistry.jsp; K. Rogers, M. R. Anver, D. H. Haines, http://web.ncifcrf.gov/rtp/lasp/phl/immuno/; Shetye et al.,1966).
Use of paraffin sections provide the easiest method for daily use and especially for retrospective use. A big advantage of paraffin sections for IHC is that one can visualize morphologic changes in cells and tissues and compare them to patterns of gene expression. Many antibodies against human antigens are successfully used with paraffin sections for human IHC, but considerably lower numbers are also effective in rodents. We and others have used specific antibodies for mouse and rat IHC for many years with paraffin sections, especially for screening the effects in lymphoid tissues; they are noted in Tables 1 and 2. For rats, less protocols have been developed for use with paraffin sections but several antibodies do work for paraffin-embedded rat tissues (Shetye et al., 1966; Whiteland et al., 1995). Our antibody screens for normal cell and tissue expression and abnormal changes in these tissues are shown in our figures (Figures 1–85). An example of a complete IHC protocol of a commonly used antibody is in Table 3. Figures 1–85 show examples of commonly used antibodies for rats and mice, most with paraffin sections. Some of the rat figures are from frozen sections, but the same antibodies are also successful with paraffin sections as noted in Table 2. The specific IHC technique and chromogen used varied for each figure shown. Most figures used hematoxylin as a counterstain.
View larger version (922K):
[in this window]
[in a new window]
|
Figure 1–8 FIGURE 1.—Mouse liver showing expression of F4/80 in Kupffer cells. 2.—Mouse lymph node with many CD3+ T-cells in the paracortex, and the cortex. 3.—Mouse lymph node with many CD40+ interdigitating dendritic cells in the paracortex. 4.—Mouse lymph node showing CD40+ cortical B-cell follicles and paracortical dendritic cells. 5.—Mouse mesenteric lymph node CD45R (B220)+ cortical B-cell follicles and medullary cords. 6.— Mouse CD45R early follicular lymphoma in Peyer’s patch of the small intestine showing disruption of normal CD45R expression pattern and enlargement of the patch. 7.—Mouse Peyer’s patch of small intestine showing IRF4 in plasma cells in the lamina propria and follicular B-cells and Bcl-6 in follicles. 8.—Mouse spleen with Bcl-2 expression in follicle, none in the germinal center and positive in PALS T-cells (darker focus).
|
|
View larger version (971K):
[in this window]
[in a new window]
|
Figure 79–85 FIGURE 79.—Rat spleen OX8 (CD8) expression in the PALS and red pulp T-cells. 80. —Rat spleen W3/13 (pan-T) in the PALS and red pulp T-cells. 81. —Rat spleen W3/25 (CD4) in many PALS cytotoxic/suppressor and red pulp+ T-cells. 82. —Rat thymus CD3 is expressed diffusely in lymphocytes of the cortex, with less in the medulla. 83. —Rat thymic ED-1 expression in scattered cells in cortex and in more cells in medulla. 84. —Rat thymus ED-2 is expressed in many cells in the cortex and none in medulla. 85. —Rat thymic OX-8 (CD8) is seen diffusely expressed cortical lymphocytes with much less in the medulla.
|
|
Basic IHC screens for T and B lymphocytes and cells of the mononuclear series are most important to characterize the basic responses to toxins. More specific cell types can be detected with frozen sections and sometimes with paraffin sections.
Importance of Antigen Retrieval Methods for Paraffin Sections
One of the challenges of Immunohistochemistry (IHC) is to develop methods that reverse changes produced during fixation. Antigen retrieval (AR) techniques reverse at least some of these changes. AR is particularly necessary when tissues are fixed in cross-linking fixatives, such as 10% neutral buffered formalin. Approximately 85% of antigens fixed in formalin require some type of AR to optimize the immunoreaction. A review by Romas-Vara (2005) provides much information, some of which is summarized here for use in rodent pathology. The two most common AR procedures used in IHC are enzymatic and heat-based retrieval.
Antigen Retrieval Using Enzymes
Protease-induced epitope retrieval (PIER) was introduced several years ago. Many enzymes have been used for this purpose, including trypsin, proteinase K, pronase, ficin, and pepsin. The effect of PIER depends on the concentration and type of enzyme, incubation parameters (time, temperature, and pH), and the duration of fixation. Use of a commercially available, ready-to-use solution of proteinase K that has good activity at room temperature can be used with automatic stainers. The disadvantages of PIER are the rather low number of antigens for which it is the optimal AR method, possible alteration of tissue morphology, and possible destruction of epitopes.
The following solutions are used in PIER methods: Proteinase K, Trypsin, Pepsin, Pronase or Protease http://www.ihcworld.com/introduction.htm#ar. These methods have been reported for restoring immunoreactivity to tissue antigens with different degrees of success. However, the use of enzyme digestion methods may destroy some epitopes and tissue morphology. Therefore the optimal enzyme concentration and incubation time needs to be established.
Proteinase Kand Trypsin methods are commonly used. The concentration, incubation time and temperature probably are the most important factors to consider:
- Concentration of enzyme is usually 0.05–0.1% depending on type of tissue and fixation.
- Incubation time can be 5–30 minutes but 10–15 minutes is most commonly used.
- Incubation temperature is usually at 37°C
Heat-Induced Epitope Retrieval
After deparaffinizing and rehydrating the tissue section, the slides are immersed in an aqueous solution commonly referred to as retrieval solution. Heat-induced epitope retrieval (HIER) was introduced several years ago. It is based on a concept developed by investigators who documented that the chemical reactions between proteins and formalin can be reversed, at least in part, by high temperature or strong alkaline hydrolysis. The mechanism involved in HIER is unknown, but its final effect is the reversion of conformational changes produced during fixation.
Key factors to be considered when performing pretreatment with HIER are: (1) the pH value of the retrieval solution that is dependent on the solution you are using, (2) the incubation time should be at least 10 minutes but is usually around 20 minutes, and (3) the temperature of retrieval solution which should be around 95°C. The following solutions are commonly used for HIER pretreatment: Hydrochloric Acid (pH 1.0), Formic Acid (pH 2.0), Citrate Buffer (pH 6.0), citrate-EDTA Buffer (pH 6.2), EDTA (pH 8.0), Tris-EDTA (pH 9.0), TBS (pH 9.0), Tris Buffer (pH 10).
The demonstration of many antigens can be significantly improved by the pretreatment with the antigen retrieval reagents that break the protein cross-links formed by formalin fixation and thereby uncover hidden antigenic sites. The techniques involved the application of heat for varying lengths of time to formalin-fixed, paraffin-embedded tissue sections in an aqueous solution (commonly referred to as the retrieval solution). This is called heat Induced epitope retrieval (HIER).
Although many different chemicals have been proposed, most retrieval solutions share a pH near 2, 6, 8, or 10. Recent systematic comparisons of several retrieval solutions showed that 0.01 M TRIS-HCL, pH 1 or 10, was slightly superior to citrate buffer of pH 6.0 and gave the best overall results http://www.ihcworld.com/introduction.htm#ar.
Microwave oven, pressure cooker, and steamer are the most commonly used heating methods. Other tools also include the use of an autoclave or water bath. The heating length of 20 minutes appears to be the most satisfactory, and the cooling usually takes about 20 minutes. Citrate buffer of pH 6.0 is the most popularly used retrieval solution and is suitable for most of antibody applications. The TRIS-EDTA of pH9.0 and EDTA of pH8.0 are second most used retrieval solutions. Proteinase K is an effective enzyme digestion reagent for membrane antigens such as Integrins, CD31, vWF, etc.
Heating at a high temperature (100°C) for a short duration (10 minutes) gives better results than those achieve with a comparatively low temperature for a longer time. However, satisfactory results are obtained in a steamer (90–95 degrees) with a 20-minute incubation for the majority of antigens needing HIER. Several HIER solutions made of different buffers (e.g., citrate, Tris) and with various pH (3–10) levels have been used. Sometimes multiple AR methods are needed to optimize the immunodetection of antigens. A combination of Heat Mediated and Proteolytic Enzyme Method is an alternative approach to unmask antigens if other methods do not work. It is especially useful for co-localization when double or triple labeling for two or three antigens co-localization is needed.
IHC for Characterizing Immunotoxicologic Pathology: Changes in Expression of Immune System Genes
Immunotoxicity and other induced lesions (e.g., infectious diseases) can be characterized by degenerative, necrotizing and proliferative changes in thymus, lymph nodes, spleen, Peyer’s patches and other tissues. Age-related changes also occur and reactive lesions in spleen and lymph nodes have been characterized in general (Ward, 1990a, 1990b, 1993 and other papers in this issue of the journal). Protein expression at an anatomical and cellular level can be measured subjectively in the microscope or by quantitative methods. IHC changes can reflect acute, subacute and chronic changes in tissues. Acute or chronic cell loss can be seen by loss of cells expressing marker antigens in a specific tissue, especially in a specific anatomical structure of that tissue (Table 4). Modification of the normal protein expression pattern in a tissue can also show changes in tissue patterns. Changes in cell or antigen distribution can be seen. Finally, proliferative lesions or lesions in which infiltrating cells are found can be found associated with increased antigen in a tissue and even in cells. All changes may be quantified using some type of automated image analysis.
IHC findings can serve as an adjunct to histopathology and biochemical and molecular findings. The total picture of immunotoxicity can be best understood by evaluation of all research findings in a study. Conclusions as to effects of dose response, cell and organ-specific toxicity and mechanisms of toxicity can best be studied by evaluation of such findings.
View larger version (1089K):
[in this window]
[in a new window]
|
Figure 9–16 FIGURE 9.—Mouse spleen with Bcl-2 expression in follicle and not in the germinal center. 10.—Mouse splenic expression of Bcl-6 in 2 germinal centers in the white pulp. 11. —Mouse splenic Bcl-6 expression in nuclei of germinal center cells. 12. —Mouse splenic CD3 expression in PALS of white pulp and in scattered cells in red pulp. 13. —Mouse spleen-CD3 expression in T-cells in the PALS. 14. —Mouse spleen showing expression of CD3 in the PALS and red pulp. 15. —Mouse spleen—CD3 in strongly positive T-cells in the PALS and less in other areas of white pulp and in red pulp. 16. —Mouse splenic CD3 strongly positive T-cells with cell membrane expression.
|
|
View larger version (1027K):
[in this window]
[in a new window]
|
Figure 17–24 FIGURE 17.—Mouse spleen-CD21 at low magnification (cytoplasmic membrane) in dendritic cells in germinal centers and marginal zone and Oct-2 (nuclear expression) in B-cell follicle. 18. —Mouse spleen—CD21 (cytoplasmic membrane) in dendritic cells in a germinal center and marginal zone and Oct-2 (nuclear) in a B-cell follicle. 19. —Mouse spleen at low magnification showing CD23 (cytoplasmic membrane) in mantle zones and Oct-2 (nuclear) in B-cell follicles. 20. —Mouse spleen—CD23 (cytoplasmic membrane) in mantle zone and Oct-2 (nuclear) in B-cell follicle. 21. —Mouse splenic CD45R in several white pulp areas, in follicles and marginal zone. 22. —Mouse splenic CD40 expression is seen in follicular and marginal zone B-cells and white pulp follicular dendritic cells. 23. —Mouse splenic CD45R (B220) at low magnification showing expression in follicles and Bcl-6 in germinal centers. 24. —Mouse splenic CD45R (B220) expression in follicle (cell membrane) and Bcl-6 (in nucleus) in germinal center.
|
|
View larger version (1838K):
[in this window]
[in a new window]
|
Figure 25–32 FIGURE 25.—Mouse splenic CD45R (B220) shows a white pulp area with many positive B-cells in a follicle, marginal zone and red pulp. 26. —Mouse spleen with CD45R expression on cell membranes of B-cell follicular lymphoma cells in various stages of differentiation. 27. —Mouse spleen—F4/80 at low magnification showing normal red pulp with many reactive red pulp macrophages. 28. —Mouse spleen—F4/80 in red pulp macrophages surrounding a white pulp area. 29. —Mouse spleen—F4/80 in red pulp macrophages of a Rag1 null mouse showing much smaller white pulp areas than in a normal immmunocompetent mouse (as in Figure 27). 30. —Mouse spleen with marked antigenic response—Human kappa light chains in numerous immunoglobulin positive plasma cells extending from the white pulp into the red pulp. 31. —Mouse splenic antigenic response—human kappa light chains in immunoglobulin-containing plasma cells extending from the white pulp into the red pulp. 32. —Mouse spleen-IRF4 in plasma cells (dark green) and mantle and marginal zones (weaker green) and Bcl-6 (red) in germinal centers.
|
|
View larger version (889K):
[in this window]
[in a new window]
|
Figure 33–40 FIGURE 33.—Mouse spleen—human kappa light chains in plasma cells in the red pulp of a mouse with myeloid hyperplasia. 34. —Mouse splenic myeloperoxidase (MPO) in myeloid cells in the red pulp. 35. —Mouse spleen -Myeloperoxidase (MPO) in myeloid cells in the red pulp at low magnification. 36. —Mouse spleen—CD45R in early nodular follicular lymphoma in one white pulp area, showing loss of normal white pulp expression pattern of CD45R. 37. —Pax-5 expression in diffuse follicular lymphoma in the mouse spleen. Note diffuse nodular pattern. 38. —Mouse splenic Pax-5 in B-cells in follicle and marginal zone. Note similarity to CD45R expression in same tissues. 39. —Pax-5 in mouse splenic marginal zone cell lymphoma (lower portion of figure). Note variable degree of nuclear expression. 40. —Mouse pax-5 expression in B-cells in follicle and marginal zone. Note variable degree of nuclear expression.
|
|
View larger version (848K):
[in this window]
[in a new window]
|
Figure 41–47 FIGURE 41.—Normal mouse spleen—Pax-5 expression in B-cells in follicles, marginal zone and red pulp. 42. —Mouse thymus—CD-3 low magnification showing many + cells in cortex and less in medulla. 43. —Mouse thymus—CD-3 showing many positive lymphocytes in cortex and fewer cells in the medulla; membrane staining is evident. 44. —Mouse thymus–CD-3 expression 48 hours after dexamethazone showing severe loss of CD3+ T-cells in the thymus. 45. —Mouse thymus–Caspase-3, expressed in apoptotic cells, is seen in some cells in a normal thymus. 46. —Mouse thymus–Caspase-3 is seen in scattered cells, 48 hours after a lymphoid toxin (dexamethazone). There is marked lymphocyte depletion. 47. —Mouse thymus–Nuclear expression of TdT in most cortical thymocytes of a normal thymus.
|
|
View larger version (895K):
[in this window]
[in a new window]
|
Figure 48–54 FIGURE 48.—Rat small intestine showing expression of OX-8 in intra-epithelial lymphocytes. 49. —Rat live—OX-8+ tumor cell membranes in liver sinusoids and blood vessels in LGL leukemia in a F344 rat. 50. —Rat liver showing OX-8 expression on cell membranes on LGL leukemia tumor cells. 51. —Rat LGL leukemia showing OX-8 exression in many tumor cells in alveolar capillaries in the lung. 52. —Rat lymph node showing CD3 in many T-cells expressing the antigen in the paracortex. 53. —Rat ED-1 in lymph node sinus histiocytes. 54. —Rat ED-2 (CD163) is expressed on cell membranes of lymph node sinus histiocytes.
|
|
View larger version (1032K):
[in this window]
[in a new window]
|
Figure 55–62 FIGURE 55.—Rat IgM is expressed in B-cells in lymph node cortical follicles and medullary plasma cells. 56. —Rat MHC II shows follicular B-cells and interdigitating dendritic cells in the node paracortex. 57. —Rat OX-8 (CD8) expressed in many T-cells in the paracortex of the lymph node. 58. —Rat W3/13 (pan-T) showing membrane staining on T-cells in the paracortex of the lymph node. 59. —Rat W3/25 (CD4)—expressing in many T-cells in the paracortex of the lymph node. 60. —Rat small intestine Peyer’s patch showing W3/25 (CD4) expresssion in interfollicular areas and less in follicles. 61. —Rat MHC II expression in follicular cells and interdigitating dendritic cells of small intestinal Peyer’s patch. 62. —Rat OX-8 (CD8) expression in interfollcular cells of small intestinal Peyer’s patch.
|
|
View larger version (1129K):
[in this window]
[in a new window]
|
Figure 63–70 FIGURE 63.—Rat spleen showing CD3 expression in the PALS and red pulp T-cells. 64. —Rat spleen showing ED-3 expression in the marginal zone macrophages. 65. —Rat spleen with ED-1 expression in red pulp macrophages. 66. —Rat spleen showing ED-1 in myeloid cells in the red pulp (focus in center) and red pulp macrophages. 67. —Rat spleen showing ED-1 expression at high magnification. 68. —Rat spleen with ED-2- expression in red pulp macrophages. 69. —Rat spleen with ED-3 expression I n marginal zone macrophages. 70. —Rat spleen showing IgD in many + cells in the follicle.
|
|
View larger version (1087K):
[in this window]
[in a new window]
|
Figure 71–78 FIGURE 71.—Rat IgM expression in the splenic marginal zone and follicular cells. 72. —Rat IgM in the splenic marginal zone and follicular cells. 73. —Rat IgM in follicle and splenic marginal zone. 74. —Rat spleen with kappa light chains expression in many plasma cells in the red pulp and marginal zone. 75. —Rat kappa light chains at high magnification showing the morphology of the typical plasma cells. 76. —Rat spleen MHC II in many B-cells in the follicles and marginal zone. 77. —MHCII in rat spleen B-cells. 78. —MHCII in rat spleen B-cells.
|
|
|
Acknowledgments
|
|---|
Dr. Ward, Cindy Erexson and Larry Faucette are supported, in part, by an NIAID Contract to SoBran, Inc.
|
References
|
|---|
- Cattoretti, G, & Fei, Q. In Shi, SR, Gu, J, & Taylor, CR (Eds.). (2000). Application of the antigen retrieval technique in experimental pathology: from human to mouse. Antigen Retrieval Techniques (pp.165-79). Natick, MA: Eaton Publishing
- Haines, DC, Chattopadhyay, S, & Ward, JM. (2001). Pathology of aging B6;129 mice. Toxicol Pathol, 29, 653-61[Abstract/Free Full Text]
- Meyer, EM, Schlake, W, & Grundmann, E. (1979). Comparative histologic, histochemical, and histomorphometric studies of T and B cell areas in peripheral lymphoid organs of normal young adult BALB/C mice. Pathol Res Pract, 164, 141-56[Web of Science][Medline]
[Order article via Infotrieve]
- Mikaelian, I, Nanneym, LB, Parman, KS, Kusewitt, DF, Ward, JM, Naf, D, Krupke, DM, Eppig, JT, Bult, CJ, Seymour, R, Ichiki, T, & Sundberg, JP. (2004). Antibodies that label paraffin-embedded mouse tissues: a collaborative endeavor. Toxicol Pathol, 32, 181-91[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Romas-Vara, JA. (2005). Review article: technical aspects of Immunohistochemistry. Vet Path, 42, 405-26[Abstract/Free Full Text]
- Shetye, JD, Scheynius, A, Mellstedt, HT, & Biberfeld, P. (1966). Retrieval of leukocyte antigens in paraffin-embedded rat tissues. J Histochem Cytochem, 44, 767-76
- van den Berg, TK, Dopp, EA, & Dijkstra, CD. (2001a). Rat macrophages: membrane glycoproteins in differentiation and function. Immunol Rev, 184, 45-57[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- van den Berg, TK, Puklavec, MJ, Barclay, AN, & Dijkstra, CD. (2001b). Monoclonal antibodies against rat leukocyte surface antigens. Immunol Rev, 184, 109-16[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ward, JM. In Jones, TC, Ward, JM, Mohr, U, & Hunt, RD (Eds.). (1990a). Classification of reactive lesions of lymph nodes. Hemopoietic System (pp.155-61). Berlin: Springer-Verlag
- Ward, JM. In Jones, TC, Ward, JM, Mohr, U, & Hunt, RD (Eds.). (1990b). Classification of reactive lesions, spleen. Hemopoietic System (pp.220-6). Berlin: Springer-Verlag
- Ward, JM, Uno, H, & Frith, CH. (1993). Immunohistochemistry and morphology of reactive lesions in lymph nodes and spleen from rats and mice. Toxicol Pathol, 21, 199-205[Abstract/Free Full Text]
- Whiteland, JL, Nicholls, SM, Shimeld, C, Easty, DL, Williams, NA, & Hill, TJ. (1995). Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem, 43, 313-20[Abstract]
Toxicologic Pathology, Vol. 34, No. 5,
616-630 (2006)
DOI: 10.1080/01926230600941340
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J. P. Sundberg, J. M. Ward, and P. Schofield
Where's the Mouse Info?
Vet. Pathol.,
November 1, 2009;
46(6):
1241 - 1244.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Poole, T. A. Wyatt, P. J. Oldenburg, M. K. Elliott, W. W. West, J. H. Sisson, S. G. Von Essen, and D. J. Romberger
Intranasal organic dust exposure-induced airway adaptation response marked by persistent lung inflammation and pathology in mice
Am J Physiol Lung Cell Mol Physiol,
June 1, 2009;
296(6):
L1085 - L1095.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. J. Buchholz, J. M. Ward, E. W. Lamirande, B. Heinze, C. D. Krempl, and P. L. Collins
Deletion of Nonstructural Proteins NS1 and NS2 from Pneumonia Virus of Mice Attenuates Viral Replication and Reduces Pulmonary Cytokine Expression and Disease
J. Virol.,
February 15, 2009;
83(4):
1969 - 1980.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Pearse
Normal Structure, Function and Histology of the Thymus
Toxicol Pathol,
August 1, 2006;
34(5):
504 - 514.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
TOP
Abstract
Introduction